| Literature DB >> 9564613 |
G Stern1.
Abstract
A proposal for the nomination of the father of monoamine oxidase inhibitors is presented. A brief history of the human clinical pharmacology of selegiline is considered including the results of two major prospective ongoing clinical trials and recent evidence on the effects of sustained selegiline therapy on postural blood pressures in parkinsonians is discussed.Entities:
Mesh：
Substances：
Year: 1998 PMID： 9564613 DOI： 10.1007/978-3-7091-6499-0_12
Source DB: PubMed Journal: J Neural Transm Suppl ISSN： 0303-6995